Nykode Therapeutics AS (OSL:NYKD) Moat Score : 4/10 (As of Jun. 28, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Moat Score?

Nykode Therapeutics AS has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Nykode Therapeutics AS has Narrow Moat: Nykode Therapeutics AS has a discernible moat due to its valuable intellectual property and ongoing R&D efforts. However, it operates in a highly competitive biotech sector with significant risks and lacks strong brand strength or market leadership.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Nykode Therapeutics AS might have Narrow Moat - Discernible but modest moat.

Competitive Comparison of Nykode Therapeutics AS's Moat Score

For the Biotechnology subindustry, Nykode Therapeutics AS's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nykode Therapeutics AS's Moat Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nykode Therapeutics AS's Moat Score distribution charts can be found below:

* The bar in red indicates where Nykode Therapeutics AS's Moat Score falls into.

Save Embed

;

Save Embed

;

Nykode Therapeutics AS (OSL:NYKD) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score	Moat Level
10	Wide Moat - Exceptionally dominant and durable wide moat
8 - 9	Wide Moat - Clear and robust wide moat
7	Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6	Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5	Narrow Moat - Solid narrow moat
4	Narrow Moat - Discernible but modest moat
1 - 3	No Moat - Very weak/transient advantages
0	No Moat - No discernible moat

Nykode Therapeutics AS Moat Score Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OSL:NYKD) » Definitions » Moat Score

Comparable Companies

Traded in Other Exchanges

VACBF:USA NYKDo:Sweden 5VB:Germany

Address

Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349

Website

https://www.nykode.com

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need. It operates in United States of America.

Nykode Therapeutics AS Headlines

No Headlines